1. Effect of an RNAi therapeutic targeting PCSK9 on atherogenic lipoproteins: Pre-specified secondary endpoints in orion 1. (August 2018) Authors: Ray, K.; Stoekenbroek, R.M.; Kallend, D.; Leiter, L.A.; Landmesser, U.; Scott-Wright, R.; Wijngaard, P.; Kastelein, J.J.P. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alirocumab efficacy and safety by body mass index: Pooled analysis from 10 Phase 3 ODYSSEY trials. (August 2018) Authors: Tinahones, F.; Laufs, U.; Cariou, B.; Yang, J.; Louie, M.J.; Thompson, D.; Leiter, L.A. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Bempedoic Acid + Ezetimibe Fixed-Dose Combination in Patients at High CVD Risk and with Elevated LDL-C Receiving Maximally Tolerated Statin Therapy. (August 2019) Authors: Ballantyne, C.; Laufs, U.; Ray, K.K.; Leiter, L.A.; Bays, H.E.; Goldberg, A.C.; Stroes, E.S.G.; MacDougall, D.; Zhao, X.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of inclisiran on haematological and immunological biomarkers: A Pooled analysis of ORION-9, -10 and -11 trial data. (August 2021) Authors: Landmesser, U.; Conde, L. Garcia; Wright, R.S.; Raal, F.J.; Koenig, W.; Leiter, L.A.; Schwartz, G.G.; Kallend, D.G.; Lawrence, D.; Ray, K.K. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of inclisiran on atherogenic lipoproteins in high-risk primary prevention populations: analysis from the phase III ORION-11 trial. (December 2020) Authors: Ray, K.K.; Kallend, D.; Leiter, L.A.; Raal, F.J.; Koenig, W.; Jaros, M.J.; Schwartz, G.G.; Landmesser, U.; Wijngaard, P.L.; Wright, R.S.; Kastelein, J.J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inclisiran reduces LDL-cholesterol independent of genotype in subjects with heterozygous familial hypercholesterolaemia. (December 2020) Authors: Raal, F.J.; Kallend, D.; Ray, K.K.; Turner, T.A.; Koenig, W.; Wright, R.S.; Wijngaard, P.L.; Curcio, D.; Jaros, M.J.; Leiter, L.A.; Landmesser, U.; Kastelein, J.J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗